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Abstract
Background: Color affects emotions, feelings, and behaviors. We hypothesized that color used in self-
monitoring of blood glucose (SMBG) is helpful for patients to recognize and act on their glucose levels to
improve glycemic control. Here, two color-indication methods, color record (CR) and color display (CD),
were independently compared for their effects on glycemic control in less frequently insulin-treated type 2
diabetes.
Subjects and Methods: One hundred twenty outpatients were randomly allocated to four groups with 2 · 2
factorial design: CR or non-CR and CD or non-CD. Blood glucose levels were recorded in red or blue pencil in
the CR arm, and a red or blue indicator light on the SMBG meter was lit in the CD arm, under hyperglycemia or
hypoglycemia, respectively. The primary end point was difference in glycated hemoglobin (HbA1c) reduction
in 24 weeks. Secondary end points were self-management performance change and psychological state change.
Results: HbA1c levels at 24 weeks were significantly decreased in the CR arm by - 0.28% but were increased
by 0.03% in the non-CR arm (P= 0.044). In addition, diet and exercise scores were significantly improved in the
CR arm compared with the non-CR arm. The exercise score showed significant improvement in the CD arm
compared with the non-CD arm but without a significant difference in HbA1c reduction. Changes in psy-
chological states were not altered between the arms.
Conclusions: CR has a favorable effect on self-management performance without any influence on psycho-
logical stress, resulting in improved glycemic control in type 2 diabetes patients using less frequent insulin
injection. Thus, active but not passive usage of color-indication methods by patients is important in successful
SMBG.
Background
Self-monitoring of blood glucose (SMBG) providesan instrument for objective feedback on the impact of daily
lifestyle habits, health conditions (e.g., illness, stress), and
medications on glucose levels. It fosters self-management and
empowers individuals to make beneficial changes in lifestyle.
The American Diabetes Association recommends that SMBG
be included in diabetes management and glycemic control for
patients onmultiple-dose insulin.1 On the other hand, there is no
consensus on the utility of SMBG for glycemic control in dia-
betes patients using less frequent insulin injection because of
controversial evidence from previous reviews.2–4
It is unclear why SMBG has no distinct effect on glycemic
control for type 2 diabetes patients with less frequent insulin
injection. However, a higher frequency of SMBG tests is
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associated with improved glycemic control in patients with
type 1 diabetes5 and also with type 2 diabetes.6 The low
frequency of SMBG tests in patients using less frequent in-
sulin injection might be a factor in the observed lack of im-
proved glycemic control. SMBG is more helpful in diabetes
management and glycemic control in conjunction with
comprehensive self-care education, skills training, and on-
going support for patients.4,7 However, many patients, es-
pecially those with less frequent SMBG, take no action when
their SMBG meter displays hyperglycemia or hypoglyce-
mia.8 The unmet need of SMBG is to find a simpler, more
efficient, and more economical method of promoting im-
provement in self-management and glycemic control.
To address this issue, we compared two separate color-
indication methods: color record (CR) and color display
(CD), both of which add color to emphasize high or low blood
glucose levels in SMBG. Color is known to directly affect
emotions, feelings, and behaviors in humans. It motivates
different cognitive learnings: red produces avoidance moti-
vation and enhances detail-oriented task; blue produces ap-
proach motivation and enhances creative task.9,10 We show
here that CR has a favorable effect on self-management
performance without any influence on psychological stress,
resulting in improved glycemic control mostly due to an in-
crease in motivation for exercise and diet.
Research Design and Methods
Participants
This study, called the Color IMPACT study (Color in
SMBG Improves self-management Performance by Ap-
proaching Cognitive Transmission), is a prospective, ran-
domized, controlled, single-center, open trial with a 2· 2
factorial design to evaluate the effect of two color-indication
methods used in SMBG—CR and CD—on glycemic control
in type 2 diabetes patients. Outpatients at Kyoto University
Hospital (Kyoto, Japan) were recruited. Inclusion criteria
were type 2 diabetes with insulins, ongoing SMBG, age be-
tween 20 and 80 years old, glycated hemoglobin (HbA1c)
levels between 7.0% and 10.5%, and ability to diet and/or
exercise. Exclusion criteria were diabetes duration of <1
year, initiation or treatment change with insulin or glucagon-
like peptide-1 receptor agonists within 4 months, SMBG
operated by other persons, severe comorbidities (e.g., severe
cardiovascular disease, liver and renal disorders, malignan-
cy), depression or psychiatric problems, impaired vision or
synesthesia, abnormal hemoglobinemia, pregnancy, inability
to follow trial procedures, or patients unsuitable for this study
as judged by physicians. The study protocol was approved by
the Institutional Review Board of Kyoto University Hospital
(protocol number E1332) and is in compliance with the
FIG. 1. The 2· 2 factorial design and the number of subjects in each group and arm. BG, blood glucose.
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Helsinki Declaration.Written informed consent was obtained
from all subjects.
Procedures
The study duration was 24 weeks. The subjects were as-
signed according to a 2 · 2 factorial design to one of four
groups (Fig. 1): (A) no CD and no CR group, (B) no CD and
CR group, (C) CD and no CR group, and (D) CD and CR
group with a randomly generated allocation code using bal-
anced design (age, gender, HbA1c, diabetes duration, and the
number of SMBG tests) in consecutively numbered sealed
envelopes.
All of the subjects visited the hospital every 4 weeks, and
laboratory data including HbA1c, frequency of SMBG tests,
and all documented medications were collected at 0, 4, 12,
and 24 weeks. Subjects completed a questionnaire on self-
management performance and psychological states at 0, 4,
12, and 24 weeks. Physicians-in-charge also filled in an
original questionnaire about SMBG at 0 and 24 weeks.
Six diabetologists and three certified diabetes nurses par-
ticipated in the study; the concepts and methods of the study
were all learned in the same manner by all participants.
Intervention
All subjects were newly provided with a blood glucose
meter (OneTouch Ultra Vue; Johnson & Johnson K.K.,
Tokyo, Japan) and instructed by one of the three nurses at
enrollment. The subjects were requested to use the meter and
record blood glucose levels manually in self-monitoring
notes during the study.
The OneTouch Ultra Vue emphasizes blood glucose levels
with five color-indicator lights (red, orange, green, light blue,
and blue), which appear in a rectangle shape (4.5mm tall·
14.5mm wide) under blood glucose value in black numbers
(14mm tall· 6–10mm wide) on a display screen (42mm
tall· 33mmwide) with white background for 180 s. In Groups
C and D, red, orange, green, light blue, and blue are shown
when blood glucose levels are ‡ 8.9mmol/L (160mg/dL),
7.3–8.8mmol/L (131–159mg/dL), 5.0–7.2mmol/L (90–
130mg/dL), 3.9–4.9mmol/L (71–89mg/dL), and < 3.8mmol/
L (70mg/dL), respectively (CD arm) (Fig. 1). However, the
indicator lights were turned off, and blood glucose levels
were shown just in black on the meter for Groups A and B
(non-CD arm).
Self-monitoring notes are provided by the Japan Associa-
tion for Diabetes Education and Care and commonly used by
patients to record blood glucose levels in Japan. In the study,
subjects in Groups A and C recorded their blood glucose levels
on the note manually in black pencil (non-CR arm). Groups B
and D recorded their blood glucose levels in black and marked
them with red or blue pencils when their glucose levels were
‡ 8.9mmol/L (160mg/dL) or < 3.8mmol/L (70mg/dL), re-
spectively (CR arm) (Fig. 1).
Measurements
The primary end point was difference in HbA1c reduction
in 24 weeks between the CR (B +D) and non-CR (A+C)
arms and the CD (C+D) and non-CD (A +B) arms. The
secondary end points were differences in self-management
performance change and psychological state change and the
difference in HbA1c reduction in 24 weeks in treatment-
unchanged subjects. Self-management performance was
evaluated by the Summary of Diabetes Self-Care Activities
Measure (SDSCA).11 The higher mean scores by subscales
indicate the higher level of each self-care practice. Psycho-
logical states were measured using a validated, abridged
version of Profile of Mood States (POMS).12 SDSCA was
used to determine the effect of color on self-management
performance, and POMS was performed because SMBG
is reported to be associated with depression.13 We also ex-
amined physicians’ attitude to SMBG because lack of phy-
sicians’ interest in the results of SMBG decreases motivation
of patients.14 The original physician questionnaire consisted
of four closed questions with a 5-point Likert scale from 0
(‘‘not at all’’) to 4 (‘‘extremely’’): physician’s satisfaction
with the physician–patient relationship; sharing a common
goal for glycemic control with patients; usefulness of SMBG
for physicians in glycemic control; and usefulness of SMBG
for patients in glycemic control. All questionnaires were
administered by certified diabetes nurses.
Statistical analysis
To examine the primary end point, the independent-
samples Student’s t test was used. The dependent-samples
Student’s t test was used to compare the means of HbA1c
levels between baseline and 24 weeks in the CR, non-CR,
CD, and non-CD arms. Similarly, the independent-samples
Student’s t test was used to compare the change in the score
on diet subscale of the SDSCA, the change in the score on all
subscales of the POMS, and the change in HbA1c levels in
24 weeks in treatment-unchanged subjects. The Mann–
Whitney nonparametric U test was applied to compare
change in the score on exercise and medications subscales
of the SDSCA because these variables were not normally
distributed. The v2 test was used to compare the ratio of
patients with improvements in the physician’s questionnaire




One hundred twenty subjects were enrolled in the study and
randomized to one of four groups: Group A, n= 31; Group B,
n=27; Group C, n=29; and GroupD, n=33. These four groups
were structured for the factorial design: a non-CR arm con-
sisting of GroupsA andC; a CR arm consisting of Groups B and
D; a non-CD arm consisting of Groups A and B; and a CD arm
consisting of Groups C and D (Fig. 1). The mean–SD age was
66.8–9.9 years old, 40.6% of the subjects were female, the
diabetes duration was 17.7– 9.3 years, the mean HbA1c level
was 7.88–0.85%, the SMBG frequency was 2.04–0.95 times
per day, and the frequency of insulin injection was 2.16– 1.09
times per day. There was no significant difference in demo-
graphic data of the subjects at the baseline among the four arms
(Table 1). No significant differences were found in the socio-
economic status or levels of education between arms (data not
shown). One hundred one of the 120 subjects (84.2%) com-
pleted the study. Nine subjects (15.0%) in the non-CR arm, 10
(16.7%) in the CR arm, nine (15.5%) in the non-CD arm, and 10
(16.1%) in the CD armwere dropped because of hospitalization
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for diabetes and comorbidities, with no significant difference
among the arms.
HbA1c findings
HbA1c levels (mean – SE) were significantly decreased in
the CR arm by - 0.28 – 0.12% (from 7.92 – 0.12% to
7.64 – 0.15%, P = 0.018) but were increased by 0.03 – 0.10%
in the non-CR arm (from 7.84– 0.12% to 7.87 – 0.16%,
P = 0.783) at 24 weeks (Fig. 2A and C). The change in HbA1c
levels in 24 weeks between the CR and non-CR arms was
significantly (P= 0.044) different at - 0.31% (95% confi-
dence interval, - 0.61 to - 0.01). On the other hand, HbA1c
levels were not significantly decreased, from 7.95 – 0.12% to
7.81 – 0.16% (P = 0.191) in the CD arm and from
7.81 – 0.12% to 7.70 – 0.15% (P= 0.334) in the non-CD arm
in 24 weeks (Fig. 2B). The change in HbA1c level in 24
weeks was - 0.14 – 0.10% in the CD arm and - 0.11 – 0.12%
in the non-CD arm with no significant difference (P= 0.866)
between the arms (- 0.03%; 95% confidence interval, - 0.33
to 0.28) (Fig. 2D). Correlation between change in HbA1c and
the number of SMBG tests (times per day) was not found in
the CR arm (Pearson’s product-moment correlation coeffi-
cient = –0.050, P= 0.728) (data not shown). The other factors
such as age, sex, socioeconomic status, and education levels
did not affect the difference in change in HbA1c between the
CR and non-CR or the CD and non-CD arms.
Treatment-unchanged subjects also were analyzed for
the effect of color on glycemic control. In these subjects, a
significant change in HbA1c level at 24 weeks was ob-
served in the CR arm compared with that in the non-CR arm
(- 0.31– 0.13% [P= 0.021] vs. 0.04– 0.11% [P= 0.715]) (Fig.
2E). The difference in change in HbA1c level between the CR
and non-CR arms was - 0.35% (95% confidence interval,
- 0.69 to - 0.02; P= 0.038). On the other hand, changes in
HbA1c level in 24 weeks were - 0.28– 0.13% in the CD arm
(P= 0.037) and 0.00– 0.11% in the non-CD arm (P= 0.981)
(Fig. 2F). The apparent difference in change in HbA1c level
between the arms was not significant (- 0.28%; 95% confi-
dence interval, - 0.62 to 0.06; P= 0.106).
Self-management performance
There were no statistically significant differences in the
baseline scores on diet, exercise, and medication subscales of
the SDSCA between the CR and non-CR arms and between
the CD and non-CD arms (Table 2). Scores on the diet and
exercise subscales of the SDSCA in 24 weeks were signifi-
cantly increased in the CR arm compared with those in the
non-CR arm. The change in diet subscale score (mean – SE)
was 0.21 – 0.15 points in the CR arm and - 0.23 – 0.16
points in the non-CR arm. The difference in change in diet
scores between the CR and non-CR arms was 0.44 points
(95% confidence interval, 0.01 to 0.87; P = 0.043). Median
change in exercise subscale score in 24 weeks was 0.50
(interquartile range, - 1.00 to 1.00) points in the CR arm
and 0.00 (interquartile range, - 1.00 to 1.00) points in the
non-CR arm with a significant difference between the arms
(P = 0.045).
Median change in the score on exercise subscale in 24
weeks was 0.50 (interquartile range, - 0.50 to 1.00) points in
the CD arm and – 0.00 (interquartile range, - 2.00 to + 0.50)
points in the non-CD arm. The difference between the arms
was statistically significant (P= 0.045), but there were no
significant differences in change in the scores of diet
(P = 0.696) and medication (P = 0.095) subscales between
arms. The change in medication subscale score was similar
between each of the two arms (CD vs. non-CD, P = 0.095; CR
vs. non-CR, P = 0.095) (Table 2).
Psychological states
The baseline scores on all subscales of POMS in each arm
were within the normal range. There were no significant
differences in all subscale scores at baseline and at 24 weeks
between the CR and non-CR arms and between the CD and
non-CD arms (data not shown).
Physicians’ perspectives on SMBG
There were no significant differences in all questions
between each of the two arms at baseline. With regard to
Question 2 (sharing a common goal for glycemic control
with patients), the scores were improved at 24 weeks from
baseline by 26.0% in the CR arm and by 9.8% in the non-CR
arm with a significant difference between the arms
(P = 0.033). However, a significant difference was not found
between the CD arm (15.4%) and the non-CD arm (20.4%)
(P = 0.510) (Table 2). There were no significant differences
in the other three questions at 24 weeks between the two
arms.
Discussion
The goal of the present study was to ascertain whether or
not two color-indication methods used in SMBG—CR and
CD—improved glycemic control through an increase in self-
management performance in less frequently insulin-treated
Table 1. Baseline Demographics for Study Subjects
Assignment by CR Assignment by CD
Variable CR (n = 60) Non-CR (n = 60) P value CD (n = 62) Non-CD (n = 58) P value
Age (years) 67.9 – 9.2 66.0 – 1.4 0.303 66.4 – 9.8 67.5 – 10.7 0.572
Female (%) 41.7 40.0 0.853 43.5 37.9 0.532
Diabetes duration (years) 17.0 – 8.7 17.0 – 9.9 0.984 17.9 – 10.2 16.0 – 8.1 0.280
HbA1c (%) 7.87 – 0.81 7.99 – 1.10 0.521 7.97 – 0.99 7.89 – 0.93 0.658
SMBG frequency (times/day) 2.28 – 1.21 1.92 – 0.77 0.059 2.21 – 1.16 1.98 – 0.85 0.227
Data are mean– SD values.
CD, color display; CR, color record; HbA1c, glycated hemoglobin; SMBG, self-monitoring of blood glucose.
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type 2 diabetes patients.We hypothesized that color-indication
methods might motivate patients to recognize hyperglycemia
and hypoglycemia and to begin problem-solving behavior.
However, only CR has a favorable effect on glycemic control,
through motivation to diet and exercise.
Correlation of change in HbA1c level and number of
SMBG tests was not found in the CR arm. In addition, the
number of SMBG tests was similar between the CR and CD
arms. It is important in SMBG usage not to merely check
blood glucose levels more frequently, but also to take action
FIG. 2. Glycated hemoglobin (HbA1c) levels during the study. (A andB)HbA1c levels during a 24-week study period in (A) the
color record (CR) and non-CR arms and the (B) color display (CD) and non-CD arms. (C andD)Change in HbA1c level during a
24-week study period in (C) the CR and non-CR arms and the (D)CD and non-CD arms. (E and F)Change in HbA1c level in the
treatment-unchanged patients during a 24-week study period in (E) the CR and non-CR arms and (F) the CD and non-CD arms.
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on the findings. Recording their blood glucose levels in blue or
red can facilitate patients’ change of behavior, as motivation to
diet and exercise was increased during the study. On the other
hand, althoughmotivation to exercise was increased, glycemic
control was not improved in the CD arm. Even though hy-
perglycemia and hypoglycemia are emphasized on the SMBG
meter in the CD arm, the information did not always cause
behavioral changes. These results suggest that active but not
passive usage is important in successful SMBG.
Action by patients is a key to improve glycemic control in
type 2 diabetes treated less frequently with insulin injection.
SMBG is recognized as one tool for such self-management.
However, it has been reported that many patients often do
nothing when blood glucose levels are high or low when
using the existing noncolor method of SMBG.8 Furthermore,
physicians’ lack of interest in the results of SMBG decreases
motivation of patients.14 However, in our study, sharing a
common goal for glycemic control was increased in the CR
arm compared with the non-CR arm, indicating that CR in
SMBG can be beneficial in promoting mutual understanding
and partnership between patients and healthcare profession-
als. As a result, self-management performance and HbA1c
levels were improved in the CR arm not only of all subjects
but also of treatment-unchanged subjects.
Change in psychological states was not observed in either
arm of the present study. The ESMON study showed that
SMBG was associated with higher scores on depression when
newly diagnosed diabetes patients were reviewed by health-
care professionals at a long-term interval (3 months).13 On the
other hand, SMBGwith adjuvant counseling at 0, 4, 12, and 20
weeks resulted in improvements for general well-being and
depression.15 In our study, all subjects were reviewed by
nurses at 0, 4, 12, and 24 weeks in addition to regular monthly
assessment by physicians. All subjects were free to ask the
nurse’s advice at any time. Reassurance is a key for continued
self-monitoring.14 Subjects in our study showed a sense of
reassurance and were not distressed by poor results of SMBG.
The potential weakness of this study is that this was a
single-center trial and that the sample size is too small to
determine whether the combination of CR and CD is more
effective for glycemic control than CR alone. However,
subanalysis suggested that CR alone has a more favorable
effect on glycemic control compared with combination of CR
and CD (data not shown), implying that too much informa-
tion for patients may not necessarily improve motivation to
life-style modification and glycemic control. Further studies
are needed to clarify which patients are more likely to benefit
from CR, CD, and other methods of SMBG.
Table 2. Scores on the Summary of Diabetes Self-Care Activities Questionnaire and Change
in the Score of the Physician’s Questionnaire in 24 Weeks
Assignment by CR Assignment by CD
Variable CR (n = 51) Non-CR (n = 50) P value CD (n = 49) Non-CD (n= 52) P value
SDSCA
Diet
Baseline 4.10 – 0.23 4.32 – 0.18 0.457 4.25 – 0.21 4.18 – 0.20 0.799
At 24 weeks 4.32 – 0.20 4.09 – 0.17 0.393 4.20 – 0.19 4.21 – 0.18 0.964
Change in score 0.21 – 0.15 - 0.23 – 0.16 0.043a - 0.05 – 0.15 - 0.03 – 0.16 0.696
Exercise
Baseline 2.75 (2.88) 4.00 (3.50) 0.097 2.75 (2.88) 4.00 (3.25) 0.062
At 24 weeks 3.00 (3.63) 3.50 (3.50) 0.138 3.00 (3.38) 3.50 (3.00) 0.688
Change in score 0.50 (2.00) 0.00 (2.00) 0.045a 0.50 (1.50) 0.00 (2.50) 0.045a
Medication
Baseline 7.00 (0.00) 7.00 (0.00) 0.058 7.00 (0.00) 7.00 (0.00) 0.723
At 24 weeks 7.00 (0.00) 7.00 (0.00) 0.436 7.00 (0.00) 7.00 (0.00) 0.379
Change in score 0.00 (0.00) 0.00 (0.00) 0.095 0.00 (0.00) 0.00 (0.00) 0.095
Physician’s questionnaireb
Question 1: Physician satisfaction? 0.215 0.689
Increase 14 (28.0) 9 (17.6) 11 (21.2) 12 (24.5)
No increase 36 (72.0) 42 (82.4) 41 (78.8) 37 (75.5)
Question 2: Shared goal? 0.033a 0.510
Increase 13 (26.0) 5 (9.8) 8 (15.4) 10 (20.4)
No increase 37 (74.0) 46 (90.2) 44 (84.6) 39 (79.6)
Question 3: Usefulness for physician? 0.231 0.203
Increase 9 (18.0) 5 (9.8) 5 (9.6) 9 (18.4)
No increase 41 (82.0) 46 (90.2) 47 (90.4) 40 (81.6)
Question 4: Usefulness for patient? 0.778 0.674
Increase 17 (34.0) 16 (31.4) 16 (30.8) 17 (34.7)
No increase 33 (66.0) 35 (68.6) 36 (69.2) 32 (65.3)
Diet data are mean– SE values. Exercise and medication data are median (interquartile range) values. Values for the physician’s
questionnaire are number (percentages).
aP< 0.05 was considered to indicate a significant difference.
bQuestion 1 was physician’s satisfaction with the physician–patient relationship; Question 2 was sharing a common goal for glycemic
control with patients; Question 3 was usefulness of self-monitoring of blood glucose for the physician in glycemic control; and Question 4
was usefulness of self-monitoring of blood glucose for the patient in glycemic control.
CD, color display; CR, color record; SDSCA, Summary of Diabetes Self-Care Activities Measure.
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In summary, CR has a favorable effect on self-management
performance without any influence on psychological stress and
results in improved glycemic control in less frequently insulin-
treated type 2 diabetes patients. Our results indicate that pro-
viding medical care and educational aid are not always helpful
for self-management; however, this might not be limited to
SMBG usage. Maintenance of a balance of intervention be-
tween patients and healthcare professionals is important for
optimized self-management.
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